Skip to main content
Premium Trial:

Request an Annual Quote

Bayer Licenses Gene Expression Technology From Genzyme Molecular

Premium

FRAMINGHAM, Mass.--Genzyme Molecular Oncology here and Bayer have inked an agreement that will allow Bayer the use of Genzyme Molecular Oncology's patented Serial Analysis of Gene Expression (SAGE) technology.

Bayer will utilize SAGE to identify genes that may have importance in drug development. Financial terms of the agreement were not disclosed.

SAGE is a patented method of simultaneously detecting and measuring the expression levels of virtually all genes expressed in a cell at a given time and can be used in a variety of applications to identify disease-related genes, analyze the effect of drugs on tissues, and provide insight into disease pathways. Because SAGE is a high-throughput method, it may be used to detect differences in rarely expressed but highly significant genes, according to Genzyme.

Filed under

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.